NINLARO™ (ixazomib) Receives Conditional Approval from the Europe
Approval Based on TOURMALINE-MM1 Study Results, Which Demonstrated Statistic...
2016-11-29
文传商讯
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLA
− If authorized, NINLARO will provide a new treatment option for Europ...
2016-09-20
文传商讯
